ID   KIS-1
AC   CVCL_M506
DR   DSMZ; ACC-947
DR   Wikidata; Q54899944
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2852183;
RX   PubMed=3034807;
RX   PubMed=8650231;
RX   PubMed=19358282;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=2852183); ~24-48 hours (DSMZ=ACC-947).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:8619; PAX5; Name(s)=PAX5-IGH (PubMed=8650231).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-947
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,13
ST   D16S539: 14
ST   D18S51: 13,20
ST   D19S433: 14
ST   D21S11: 29,32
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 15,17
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=2852183; DOI=10.1111/j.1349-7006.1988.tb01544.x; PMCID=PMC5917646;
RA   Kamesaki H., Miwa H., Ohno Y., Miyanishi S., Yamabe H., Doi S.,
RA   Arita Y., Ohno H., Tatsumi E., Nishikori M., Fukuhara S., Hatanaka M.,
RA   Uchino H.;
RT   "A novel B cell line established from Ki-1-positive diffuse large cell
RT   lymphoma.";
RL   Jpn. J. Cancer Res. 79:1193-1200(1988).
//
RX   PubMed=3034807; DOI=10.1002/ijc.2910390622;
RA   Ohno H., Fukuhara S., Takahashi R., Mihara K.-i., Sugiyama T., Doi S.,
RA   Uchino H., Toyoshima K.;
RT   "c-yes and bcl-2 genes located on 18q21.3 in a follicular lymphoma
RT   cell line carrying a t(14;18) chromosomal translocation.";
RL   Int. J. Cancer 39:785-788(1987).
//
RX   PubMed=8650231; DOI=10.1073/pnas.93.12.6129; PMCID=PMC39201;
RA   Busslinger M., Klix N., Pfeffer P., Graninger P.G., Kozmik Z.;
RT   "Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH
RT   locus adjacent to two alternative PAX-5 promoters in a diffuse
RT   large-cell lymphoma.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:6129-6134(1996).
//
RX   PubMed=19358282; DOI=10.1002/ijc.24351;
RA   Inagaki A., Ishida T., Yano H., Ishii T., Kusumoto S., Ito A., Ri M.,
RA   Mori F., Ding J.-M., Komatsu H., Iida S., Ueda R.;
RT   "Expression of the ULBP ligands for NKG2D by B-NHL cells plays an
RT   important role in determining their susceptibility to
RT   rituximab-induced ADCC.";
RL   Int. J. Cancer 125:212-221(2009).
//